Hypophosphatasia Clinical Trials

7 recruiting

Hypophosphatasia Trials at a Glance

8 actively recruiting trials for hypophosphatasia are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Phase 1 with 1 trial, with the heaviest enrollment activity in Kansas City, Boston, and Charlottesville. Lead sponsors running hypophosphatasia studies include Alexion Pharmaceuticals, Inc., Assistance Publique - Hôpitaux de Paris, and Alesta Therapeutics.

Browse hypophosphatasia trials by phase

Treatments under study

About Hypophosphatasia Clinical Trials

Looking for clinical trials for Hypophosphatasia? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hypophosphatasia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hypophosphatasia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

The Effect of Monoallelic Variants in the ALPL Gene on the Natural Course of Hypophosphatasia in Russia

Hypophosphatasia
AstraZeneca55 enrolled4 locationsNCT07390240
Recruiting

Natural History Study of Patients With Hypophosphatasia (HPP)

Hypophosphatasia
Duke University200 enrolled1 locationNCT02237625
Recruiting

A Prospective Sub-Study of the Global Hypophosphatasia Registry

Hypophosphatasia
Alexion Pharmaceuticals, Inc.30 enrolled12 locationsNCT05234567
Recruiting
Phase 1Phase 2

A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALE1 in Healthy Adults and Adults With Hypophosphatasia in Order to Identify Suitable Doses of ALE1

Hypophosphatasia (HPP)
Alesta Therapeutics120 enrolled2 locationsNCT07179640
Recruiting

Prospective, Longitudinal, Observational Registry of Adult Patients With Hypophosphatasia (REG-HYPO)

Hypophosphatasia
Assistance Publique - Hôpitaux de Paris130 enrolled11 locationsNCT05596539
Recruiting

United States Hypophosphatasia Molecular Research Center

Hypophosphatasia
Children's Mercy Hospital Kansas City66 enrolled1 locationNCT05062629
Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+188 more
Sanford Health20,000 enrolled2 locationsNCT01793168
Recruiting

Characteristics of Hypophosphatasia in Adult Patients in Rheumatology and Their Value in Developing an Algorithm to HPP-diagnosis - the COHIR Multi-center Study

Hypophosphatasia
University of Bonn720 enrolled1 locationNCT06574282